{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T03:12:03Z","timestamp":1789269123241,"version":"build-2803163510"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:00:00Z","timestamp":1694995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Background and objective<\/jats:title><jats:p>Mixed bacterial infections (MBI) is one of the complications after hematopoietic stem cell transplantation (HSCT) and increases the risk of patient death. However, there are few reports specifically on this topic. The purpose of this study was to investigate the clinical characteristics and mortality risk factors of MBI in HSCT recipients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The electronic medical records of patients undergoing HSCT were collected. The epidemiological features and antibiotic resistance of patients with and without MBI were compared. Logistic regression and Cox regression were used to identify the risk factors for MBI acquisition and death. R language was used to construct a prediction model for the overall survival of HSCT recipients with MBI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The cumulative incidence of MBI was 6.3% and the mortality was 48.8%. Time interval from diagnosis to transplantation &amp;gt; 180 days (HR=2.059, 95% CI 1.042-4.069, <jats:italic>P<\/jats:italic>=0.038) and ICU admission after transplantation (HR=2.271, 95% CI 1.053-4.898, <jats:italic>P<\/jats:italic>=0.036) were independent risk factors for MBI acquisition. Engraftment period &amp;gt; 20 days (HR=2.273, 95% CI 1.028-5.027, <jats:italic>P<\/jats:italic>=0.043), continuous renal replacement therapy (HR=5.755, 95% CI 1.691-19.589, <jats:italic>P<\/jats:italic>=0.005) and septic shock (HR=4.308, 95% CI 2.085-8.901, <jats:italic>P<\/jats:italic>=0.000) were independent risk factors associated with mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>MBI has become a serious problem that cannot be ignored after HSCT. It is urgent for clinicians to pay high attention to it and formulate reasonable monitoring and treatment plans to improve the prognosis of patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2023.1223824","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T06:20:45Z","timestamp":1695104445000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical characteristics and mortality risk factors of mixed bacterial infections in hematopoietic stem cell transplantation recipients"],"prefix":"10.3389","volume":"13","author":[{"given":"Yanfeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ccc.2009.09.001","article-title":"Critical care of the hematopoietic stem cell transplant recipient","volume":"26","author":"Afessa","year":"2010","journal-title":"Crit. Care Clin."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab371","article-title":"Real-world, multicenter experience with meropenem-vaborbactam for gram-negative bacterial infections including carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa","volume":"8","author":"Alosaimy","year":"2021","journal-title":"Open Forum. Infect. Dis."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20051215","article-title":"Coagulase-negative staphylococci pathogenomics","volume":"20","author":"Argemi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1093\/cid\/cix646","article-title":"Antimicrobial resistance in Gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: intercontinental prospective study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group","volume":"65","author":"Averbuch","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2015.045","article-title":"Bacterial infections in hematopoietic stem cell transplant recipients","volume":"7","author":"Balletto","year":"2015","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/16078454.2021.1905355","article-title":"Infections in hematopoietic stem cell transplant patients admitted to hematology intensive care unit: a single-center study","volume":"26","author":"Barlas","year":"2021","journal-title":"Hematology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3747\/co.26.5033","article-title":"A general practitioner's guide to hematopoietic stem-cell transplantation","volume":"26","author":"Bazinet","year":"2019","journal-title":"Curr. Oncol."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18031003","article-title":"Reduction of multidrug-resistant (MDR) bacterial infections during the COVID-19 pandemic: A retrospective study","volume":"18","author":"Bentivegna","year":"2021","journal-title":"Int. J. Environ. Res. Public. Health"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.soncn.2019.150950","article-title":"Acute leukemia: diagnosis and treatment","volume":"35","author":"Blackburn","year":"2019","journal-title":"Semin. Oncol. Nurs."},{"key":"B10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2147\/IDR.S280869","article-title":"Clinical analysis of bloodstream infections during agranulocytosis after allogeneic hematopoietic stem cell transplantation","volume":"14","author":"Cao","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-02278-5","article-title":"The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies","author":"Carreras","year":"2019"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00295","article-title":"Hematopoietic stem cell transplantation in primary immunodeficiency diseases: current status and future perspectives","volume":"7","author":"Castagnoli","year":"2019","journal-title":"Front. Pediatr."},{"key":"B13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","article-title":"Sepsis and septic shock","volume":"392","author":"Cecconi","year":"2018","journal-title":"Lancet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"S480","DOI":"10.1093\/ofid\/ofy210.1374","article-title":"1546. Incidence of carbapenemase-Producing Klebsiella pneumoniae colonization in hematopoietic stem cell transplant recipients in King Chulalongkorn Memorial Hospital (KCMH), Thailand","volume":"5","author":"Chueansuwan","year":"2018","journal-title":"Open Forum. Infect. Dis."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2021.106335","article-title":"The place of ceftazidime\/avibactam and ceftolozane\/tazobactam for therapy of haematological patients with febrile neutropenia","volume":"57","author":"Clerici","year":"2021","journal-title":"Int. J. Antimicrob. Agents."},{"key":"B16","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.cmi.2019.04.013","article-title":"Management of carbapenem-resistant Enterobacteriaceae infections","volume":"25","author":"Durante-Mangoni","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.632263","article-title":"Continuous renal replacement therapy: a review of use and application in pediatric hematopoietic stem cell transplant recipients","volume":"11","author":"Elbahlawan","year":"2021","journal-title":"Front. Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1038\/s41409-021-01328-4","article-title":"Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide","volume":"56","author":"Esquirol","year":"2021","journal-title":"Bone Marrow. Transplantation."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit. Care Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00520-021-06640-9","article-title":"Clinical characteristics and outcome of 125 polymicrobial bloodstream infections in hematological patients: an 11-year epidemiologic survey","volume":"30","author":"Facchin","year":"2022","journal-title":"Support. Care Cancer."},{"key":"B21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jhin.2018.03.004","article-title":"Epidemiology, risk factors and outcomes of multi-drug-resistant bloodstream infections in haematopoietic stem cell transplant recipients: importance of previous gut colonization","volume":"100","author":"Ferreira","year":"2018","journal-title":"J. Hosp. Infect."},{"key":"B22","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-323-79135-9.00019-7","volume-title":"Infectious complications from vascular access","author":"Fisher","year":"2023"},{"key":"B23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/bmt.2016.234","article-title":"Control of infectious mortality due to carbapenemase-producing Klebsiella pneumoniae in hematopoietic stem cell transplantation","volume":"52","author":"Forcina","year":"2017","journal-title":"Bone Marrow. Transplant."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12730","article-title":"Epidemiology of bloodstream infections after myeloablative and non-myeloablative allogeneic hematopoietic stem cell transplantation: A single-center cohort study","volume":"19","author":"Gjaerde","year":"2017","journal-title":"Transpl. Infect. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s40265-021-01471-8","article-title":"Imipenem\/Cilastatin\/Relebactam: a review in gram-negative bacterial infections","volume":"81","author":"Heo","year":"2021","journal-title":"Drugs"},{"key":"B26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am. J. Infect. Control."},{"key":"B27","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3760\/cma.j.issn.0253-2727.2020.11.018","article-title":"Advance in hematopoietic and immune reconstitution of allogeneic stem cell transplantation","volume":"41","author":"Huo","year":"2020","journal-title":"Zhonghua Xue Ye Xue Za Zhi."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1098856","article-title":"Epidemiology, antimicrobial resistance, and mortality risk factors of carbapenem resistant gram-negative bacteria in hematopoietic stem cell transplantation recipients","volume":"12","author":"Jia","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/tid.12345","article-title":"Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation","volume":"17","author":"Kikuchi","year":"2015","journal-title":"Transpl. Infect. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.18620\/ctt-1866-8836-2018-7-1-8-17","article-title":"Infection and GVHD","volume":"7","author":"Kolb","year":"2018","journal-title":"Cell. Ther. Transplant."},{"key":"B31","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/sdi.12970","article-title":"Complications associated with continuous renal replacement therapy","volume":"34","author":"Kovvuru","year":"2021","journal-title":"Semin. Dial."},{"key":"B32","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jgar.2019.09.006","article-title":"Risk factors for carbapenem-resistant Klebsiella pneumoniae infection: a meta-analysis","volume":"24","author":"Liu","year":"2018","journal-title":"Microb. Drug Resist."},{"key":"B33","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.2147\/IDR.S376763","article-title":"Epidemiology, drug resistance, and risk factors for mortality among hematopoietic stem cell transplantation recipients with hospital-acquired Klebsiella pneumoniae infections: a single-center retrospective study from China","volume":"15","author":"Liu","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"B34","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/tid.12298","article-title":"Changing microbial epidemiology in hematopoietic stem cell transplant recipients: increasing resistance over a 9-year period","volume":"16","author":"Macesic","year":"2014","journal-title":"Transpl. Infect. Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1016\/j.bbmt.2018.06.002","article-title":"Gastrointestinal graft-versus-host disease is a risk factor for postengraftment bloodstream infection in allogeneic hematopoietic stem cell transplant recipients","volume":"24","author":"Mori","year":"2018","journal-title":"Biol. Blood. Marrow. Transplant."},{"key":"B36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1086\/595846","article-title":"Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry","volume":"48","author":"Neofytos","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.14748\/ssm.v54i2.8223","article-title":"Species diversity and antimicrobial resistance of Staphylococcus spp. isolates associated with catheter-related bloodstream infections in patients after hematopoietic stem cell transplantation","volume":"54","author":"Niyazi","year":"2022","journal-title":"Scripta Scientifica Medica."},{"key":"B38","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.hemonc.2017.05.018","article-title":"Complications of hematopoietic stem cell transplantation: bacterial infections","volume":"10","author":"Omrani","year":"2017","journal-title":"Hematol. Oncol. Stem. Cell. Ther."},{"key":"B39","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.bbmt.2016.11.005","article-title":"Risk factors and outcomes of infections by multidrug-resistant gram-negative bacteria in patients undergoing hematopoietic stem cell transplantation","volume":"23","author":"Patriarca","year":"2017","journal-title":"Biol. Blood. Marrow. Transplant."},{"key":"B40","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/cid\/ciz816","article-title":"Ceftolozane\/Tazobactam vs polymyxin or aminoglycoside-based regimens for the treatment of drug-resistant Pseudomonas aeruginosa","volume":"71","author":"Pogue","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000485634","article-title":"From continuous renal replacement therapies to multiple organ support therapy","volume":"194","author":"Ricci","year":"2018","journal-title":"Contrib. Nephrol."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1177\/20499361211053480","article-title":"Prevention and management of carbapenem-resistant Enterobacteriaceae in haematopoietic cell transplantation","volume":"8","author":"Sahitya","year":"2021","journal-title":"Ther. Adv. Infect. Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41409-019-0624-z","article-title":"Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors","volume":"55","author":"Styczynski","year":"2020","journal-title":"Bone Marrow. Transplant."},{"key":"B44","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00520-021-06447-8","article-title":"Intensive oral care can reduce bloodstream infection with coagulase-negative staphylococci after neutrophil engraftment in allogeneic hematopoietic stem-cell transplantation","volume":"30","author":"Suwabe","year":"2022","journal-title":"Support. Care Cancer."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1002\/cam4.3896","article-title":"Late-occurring infections in a contemporary cohort of hematopoietic cell transplantation survivors","volume":"10","author":"Sy","year":"2021","journal-title":"Cancer. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.chest.2018.09.004","article-title":"Continuous renal replacement therapy: who, when, why, and how","volume":"155","author":"Tandukar","year":"2019","journal-title":"Chest."},{"key":"B47","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/tid.12363","article-title":"Polymicrobial bacterial or fungal infections: incidence, spectrum of infection, risk factors, and clinical outcomes from a large hematopoietic stem cell transplant center","volume":"17","author":"Trifilio","year":"2015","journal-title":"Transpl. Infect. Dis."},{"key":"B48","first-page":"348","article-title":"Clinical analysis of blood stream infection during early period after hematopoietic stem cell transplantation","volume":"32","author":"Wang","year":"2019","journal-title":"J. Clin. Hematol. (China)."},{"key":"B49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13045-018-0564-x","article-title":"The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China\u2014recommendations from the Chinese Society of Hematology","volume":"11","author":"Xu","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/1757177416655472","article-title":"Infection risks associated with peripheral vascular catheters","volume":"17","author":"Zhang","year":"2016","journal-title":"J. Infect. Prev."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1223824\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T06:20:53Z","timestamp":1695104453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1223824\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,18]]},"references-count":50,"alternative-id":["10.3389\/fcimb.2023.1223824"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2023.1223824","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,18]]},"article-number":"1223824"}}